Defence Therapeutics is a Canadian Biotech company developing next generation bio-pharmaceutical innovations for various immuno-oncology (IO) and infectious diseases (ID) indications.

Defence Therapeutics is a publicly-traded biotechnology company working on engineering the next generation vaccines and ADC products using its proprietary platform.

Frequency Exchange is focused on the development and commercialization of a frequency emitter to markets worldwide, delivering specialized packages designed for health and wellness as well as performance enhancement.

Global Healthcare Management is active management and distributions program. It will gain knowledge of the established and emerging concept.